Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
433.043%
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
345.513%
|
IO Biotech, Inc.
|
-1.98 USD
|
293.434%
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
238.267%
|
Organovo Holdings, Inc.
|
-1.60 USD
|
339.375%
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
171.857%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
479.208%
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
101.748%
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
256.967%
|
Savara Inc.
|
-0.33 USD
|
1260.606%
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
233.449%
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
231.164%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
137.148%
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
100.351%
|
Soligenix, Inc.
|
-12.66 USD
|
130.253%
|
Aptose Biosciences Inc.
|
-7.58 USD
|
150.528%
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
171.19%
|
Century Therapeutics, Inc.
|
-2.30 USD
|
266.522%
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
193.873%
|
Precision BioSciences, Inc.
|
-15.96 USD
|
123.997%
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
172.676%
|
Kura Oncology, Inc.
|
-2.08 USD
|
284.135%
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
241.328%
|
Dyadic International, Inc.
|
-0.24 USD
|
1695.833%
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
381.618%
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
295.408%
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
49840.26%
|
Autolus Therapeutics plc
|
-1.20 USD
|
419.167%
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
10593.151%
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
310.44%
|
GRI Bio, Inc.
|
-28.25 USD
|
113.558%
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
327.976%
|
IGM Biosciences, Inc.
|
-4.71 USD
|
181.316%
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
578.75%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
150.131%
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
107.999%
|
Opthea Limited
|
-0.35 USD
|
1194.286%
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
771.93%
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
105.876%
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
239.273%
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
-26.821%
|
Surrozen, Inc.
|
-21.33 USD
|
117.956%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
243.985%
|
Cingulate Inc.
|
-311.99 USD
|
101.228%
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
617.568%
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
379.562%
|
Acelyrin, Inc.
|
-5.43 USD
|
170.534%
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
343.949%
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
131.088%
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
441.964%
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
165.921%
|
ADMA Biologics, Inc.
|
-0.13 USD
|
3046.154%
|
PureTech Health plc
|
-2.38 USD
|
260.924%
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
128.518%
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
749.153%
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
300.524%
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
251.984%
|
Synaptogenix, Inc.
|
-29.56 USD
|
112.957%
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
2493.75%
|
ChromaDex Corporation
|
-0.07 USD
|
5911.836%
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
207.283%
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
760.345%
|
Exelixis, Inc.
|
0.65 USD
|
-489.231%
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
1467.857%
|
Better Therapeutics, Inc.
|
-1.69 USD
|
326.627%
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
244.528%
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
186.067%
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
358.784%
|
Seer, Inc.
|
-1.35 USD
|
383.704%
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
333.537%
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
343.949%
|
Gritstone bio, Inc.
|
-1.20 USD
|
419.167%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
161.974%
|
Avid Bioservices, Inc.
|
-2.23 USD
|
271.749%
|
Insmed Incorporated
|
-5.34 USD
|
171.723%
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
100.002%
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
103.372%
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
333.537%
|
MediWound Ltd.
|
-0.75 USD
|
610.667%
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
162.276%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
145.218%
|
OmniAb, Inc.
|
-0.51 USD
|
850.98%
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
530.337%
|
Zai Lab Limited
|
-3.46 USD
|
210.694%
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
200.0%
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
182.9%
|
Veracyte, Inc.
|
-1.02 USD
|
475.49%
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
251.383%
|
FibroGen, Inc.
|
-2.92 USD
|
231.164%
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
112747.059%
|
ContextLogic Inc.
|
-13.36 USD
|
128.668%
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
377.536%
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
170.404%
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
144.38%
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
44.892%
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
2015.0%
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
114.318%
|
ImmuCell Corporation
|
-0.75 USD
|
610.667%
|
Fortrea Holdings Inc.
|
-0.04 USD
|
10100.0%
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
211.337%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
161.974%
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
263.675%
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
146.424%
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
483.0%
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
310.44%
|
Vaxxinity, Inc.
|
-0.45 USD
|
951.111%
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
424.576%
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
323.977%
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
201.862%
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
298.446%
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
289.604%
|
Senti Biosciences, Inc.
|
-16.01 USD
|
123.923%
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
255.061%
|
Apollomics, Inc.
|
-2.32 USD
|
265.086%
|
89bio, Inc.
|
-2.00 USD
|
291.5%
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
300.524%
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
103.697%
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
225.574%
|
Ardelyx, Inc.
|
-0.30 USD
|
1376.667%
|
Pluri Inc.
|
-3.99 USD
|
195.99%
|
Prothena Corporation plc
|
-2.76 USD
|
238.768%
|
Pulmatrix, Inc.
|
-3.87 USD
|
198.966%
|
Celularity Inc.
|
-11.02 USD
|
134.755%
|
MeiraGTx Holdings plc
|
-1.49 USD
|
357.047%
|
Omeros Corporation
|
-1.88 USD
|
303.723%
|
Ainos, Inc.
|
-3.36 USD
|
213.988%
|
Humacyte, Inc.
|
-1.07 USD
|
457.944%
|
Mesoblast Limited
|
-0.89 USD
|
530.337%
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
305.914%
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
172.952%
|
Blueprint Medicines Corporation
|
-8.37 USD
|
145.759%
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
332.121%
|
Summit Therapeutics Inc.
|
-0.99 USD
|
486.869%
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
117.433%
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
292.462%
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
170.664%
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
152.755%
|
Cytokinetics, Incorporated
|
-5.45 USD
|
170.275%
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
123.003%
|
Nutriband Inc.
|
-0.69 USD
|
655.072%
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
207.283%
|
Roivant Sciences Ltd.
|
5.55 USD
|
30.991%
|
Evogene Ltd.
|
-5.23 USD
|
173.231%
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
369.718%
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
266.522%
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
196.962%
|
BioLineRx Ltd.
|
-0.94 USD
|
507.447%
|
Atai Life Sciences N.V.
|
-0.25 USD
|
1632.0%
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
351.974%
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
809.259%
|
MediciNova, Inc.
|
-0.17 USD
|
2352.941%
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
120.492%
|
MiMedx Group, Inc.
|
0.48 USD
|
-697.917%
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
145.759%
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
203.794%
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
228.523%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
130.277%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
196.231%
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
248.45%
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
196.962%
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
-1815.0%
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
216.061%
|
Allakos Inc.
|
-2.14 USD
|
278.972%
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
340.881%
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
-275.49%
|
BioAtla, Inc.
|
-2.58 USD
|
248.45%
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
283.254%
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
555.952%
|
Precigen, Inc.
|
-0.39 USD
|
1082.051%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
1420.69%
|
XOMA Corporation
|
-4.04 USD
|
194.802%
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
373.571%
|
Incyte Corporation
|
2.67 USD
|
-43.446%
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
274.886%
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
208.807%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
406.4%
|
CRISPR Therapeutics AG
|
-1.94 USD
|
297.423%
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
232.526%
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
394.615%
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
250.787%
|
UroGen Pharma Ltd.
|
-3.55 USD
|
207.887%
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
315.169%
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
183.261%
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
248.45%
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
260.924%
|
Chimerix, Inc.
|
-0.93 USD
|
511.828%
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
181.144%
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
503.158%
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
160.031%
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
196.962%
|
Portage Biotech Inc.
|
-3.70 USD
|
203.514%
|
OncoCyte Corporation
|
-3.75 USD
|
202.133%
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
255.691%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
717.742%
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
145.165%
|
Purple Biotech Ltd.
|
-0.09 USD
|
4365.033%
|
NextCure, Inc.
|
-2.25 USD
|
270.222%
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
369.718%
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
109.532%
|
Generation Bio Co.
|
-1.96 USD
|
295.408%
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
357.047%
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
951.111%
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
274.091%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
1296.875%
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
292.462%
|
Novavax, Inc.
|
-5.41 USD
|
170.795%
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
1467.857%
|
Curis, Inc.
|
-8.96 USD
|
142.746%
|
Daré Bioscience, Inc.
|
-4.15 USD
|
192.289%
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
151.687%
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
129.53%
|
Bicycle Therapeutics plc
|
-5.08 USD
|
175.394%
|
BeiGene, Ltd.
|
-8.45 USD
|
145.325%
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
117.889%
|
Alector, Inc.
|
-1.56 USD
|
345.513%
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
375.54%
|
Erasca, Inc.
|
-0.83 USD
|
561.446%
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
238.267%
|
Aura Biosciences, Inc.
|
-1.93 USD
|
298.446%
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
390.152%
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
285.922%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
433.043%
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
117.569%
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
-330.337%
|
Histogen Inc.
|
-3.46 USD
|
210.694%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
145.218%
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
231.615%
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
511.828%
|
Galecto, Inc.
|
-36.08 USD
|
110.615%
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
479.208%
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
197.455%
|
Molecular Templates, Inc.
|
-1.80 USD
|
312.778%
|
PDS Biotechnology Corporation
|
-1.39 USD
|
375.54%
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
-424.658%
|
Amarin Corporation plc
|
-0.15 USD
|
2653.333%
|
TG Therapeutics, Inc.
|
0.09 USD
|
-4188.914%
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
106.116%
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
231.164%
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
258.264%
|
Onconetix, Inc.
|
-2.19 USD
|
274.886%
|
MacroGenics, Inc.
|
-0.15 USD
|
2653.333%
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
881.633%
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
932.609%
|
Adagene Inc.
|
-0.44 USD
|
970.455%
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
174.805%
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
109.014%
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
-24.351%
|
SciSparc Ltd.
|
-14.43 USD
|
126.542%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
822.642%
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
183.08%
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
258.264%
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
303.723%
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
201.323%
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
237.276%
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
208.807%
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
148.79%
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
209.742%
|
2seventy bio, Inc.
|
-4.42 USD
|
186.652%
|
Clene Inc.
|
-9.43 USD
|
140.615%
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
272.523%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
137.476%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
121.114%
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
970.455%
|
Scopus BioPharma Inc.
|
-0.55 USD
|
796.364%
|
Absci Corporation
|
-1.20 USD
|
419.167%
|
XBiotech Inc.
|
-0.81 USD
|
572.84%
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
202.406%
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
403.968%
|
Entera Bio Ltd.
|
-0.31 USD
|
1335.484%
|
Trevena, Inc.
|
-54.51 USD
|
107.026%
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
771.93%
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
377.536%
|
INmune Bio, Inc.
|
-1.67 USD
|
329.341%
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
1840.909%
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
336.42%
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
112.745%
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
241.852%
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
112.319%
|
Jaguar Health, Inc.
|
-107.42 USD
|
103.565%
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
822.642%
|
NexImmune, Inc.
|
-30.82 USD
|
112.427%
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
454.63%
|
Clearmind Medicine Inc.
|
-59.18 USD
|
106.472%
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
561.446%
|
Kronos Bio, Inc.
|
-1.95 USD
|
296.41%
|
Innoviva, Inc.
|
2.92 USD
|
-31.164%
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
251.383%
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
89.663%
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
309.29%
|
Verastem, Inc.
|
-3.96 USD
|
196.717%
|
ProKidney Corp.
|
-0.57 USD
|
771.93%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
1082.051%
|
Imunon, Inc.
|
-2.16 USD
|
277.315%
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
520.879%
|
Statera Biopharma, Inc.
|
-4.97 USD
|
177.062%
|
ImmunityBio, Inc.
|
-1.15 USD
|
433.043%
|
Korro Bio, Inc.
|
-53.08 USD
|
107.216%
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
355.333%
|
Kineta, Inc.
|
-1.28 USD
|
399.219%
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
-471.642%
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
561.446%
|
GT Biopharma, Inc.
|
-5.64 USD
|
167.908%
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
173.654%
|
Celularity Inc.
|
-11.02 USD
|
134.755%
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
203.794%
|
CalciMedica, Inc.
|
-7.65 USD
|
150.065%
|
Cibus, Inc.
|
-25.95 USD
|
114.759%
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
243.446%
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
245.627%
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
239475.0%
|
Kodiak Sciences Inc.
|
-4.97 USD
|
177.062%
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
362.329%
|
Annexon, Inc.
|
-1.77 USD
|
316.384%
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
132.96%
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
128.625%
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
155.029%
|
Moderna, Inc.
|
-12.34 USD
|
131.037%
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
279.812%
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
249.609%
|
Vor Biopharma Inc.
|
-1.75 USD
|
318.857%
|
Eyenovia, Inc.
|
-0.66 USD
|
680.303%
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
738.333%
|
Puma Biotechnology, Inc.
|
0.46 USD
|
-732.609%
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
245.627%
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
809.259%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
4336.726%
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
1135.135%
|
Immunocore Holdings plc
|
-1.13 USD
|
438.938%
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
454.63%
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
617.568%
|
Alkermes plc
|
2.14 USD
|
-78.972%
|
Arcellx, Inc.
|
-1.47 USD
|
360.544%
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
555.952%
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
185.682%
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
243.985%
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
342.405%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
680.303%
|
Moolec Science SA
|
-1.50 USD
|
355.333%
|
Biomea Fusion, Inc.
|
-3.44 USD
|
211.337%
|
RenovoRx, Inc.
|
-0.99 USD
|
486.869%
|
Geron Corporation
|
-0.32 USD
|
1296.875%
|
Mereo BioPharma Group plc
|
-0.04 USD
|
8668.233%
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
358.784%
|
Royalty Pharma plc
|
3.41 USD
|
-12.317%
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
334.969%
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
655.072%
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
148.237%
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
132.321%
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
358.784%
|
Humacyte, Inc.
|
-1.07 USD
|
457.944%
|
Structure Therapeutics Inc.
|
-2.44 USD
|
256.967%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
1296.875%
|
Genelux Corporation
|
-1.16 USD
|
430.172%
|
ESSA Pharma Inc.
|
-0.60 USD
|
738.333%
|
aTyr Pharma, Inc.
|
-0.94 USD
|
507.447%
|
Notable Labs, Ltd.
|
-5.03 USD
|
176.143%
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
126.019%
|
Mustang Bio, Inc.
|
-6.00 USD
|
163.833%
|
Immunovant, Inc.
|
-1.88 USD
|
303.723%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
957600.0%
|
Vericel Corporation
|
-0.07 USD
|
5824.963%
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
-79.812%
|
Akari Therapeutics, Plc
|
-2.04 USD
|
287.745%
|
Acasti Pharma Inc.
|
-1.35 USD
|
383.704%
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
689.231%
|
Vaxcyte, Inc.
|
-4.14 USD
|
192.512%
|
Orgenesis Inc.
|
-1.91 USD
|
300.524%
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
408.871%
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
255.691%
|
GH Research PLC
|
-0.68 USD
|
663.235%
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
300.524%
|
PepGen Inc.
|
-3.30 USD
|
216.061%
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
125.415%
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
216.768%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
1420.69%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
243.985%
|
Silo Pharma, Inc.
|
-1.20 USD
|
419.167%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
970.455%
|
Belite Bio, Inc
|
-1.19 USD
|
421.849%
|
Pharming Group N.V.
|
-0.16 USD
|
2493.75%
|
XOMA Corporation
|
-4.04 USD
|
194.802%
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
115.18%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
406.4%
|
Bionomics Limited
|
-1.02 USD
|
475.49%
|
Xencor, Inc.
|
-2.08 USD
|
284.135%
|
Replimune Group, Inc.
|
-3.24 USD
|
218.21%
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
307.027%
|
Cassava Sciences, Inc.
|
-2.32 USD
|
265.086%
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
-8664.302%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
1923.81%
|
Turnstone Biologics Corp.
|
-4.77 USD
|
180.294%
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
104.153%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
137.476%
|
MEI Pharma, Inc.
|
2.67 USD
|
-43.446%
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
278.972%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
680.303%
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
111.385%
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
345.513%
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
717.742%
|
scPharmaceuticals Inc.
|
-1.42 USD
|
369.718%
|
HilleVax, Inc.
|
-3.04 USD
|
225.987%
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
270.222%
|
Tharimmune, Inc.
|
-107.08 USD
|
103.577%
|
Genprex, Inc.
|
-22.58 USD
|
116.962%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
112.644%
|
Immunic, Inc.
|
-2.11 USD
|
281.517%
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
1695.833%
|
Aptorum Group Limited
|
-0.62 USD
|
717.742%
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
262.288%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
112.644%
|
OKYO Pharma Limited
|
-0.00 USD
|
638433.333%
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
362.329%
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
355.333%
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
14662.738%
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
850.98%
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
100889.474%
|
bluebird bio, Inc.
|
-1.93 USD
|
298.446%
|
DBV Technologies S.A.
|
-0.76 USD
|
603.947%
|
Compugen Ltd.
|
-0.21 USD
|
1923.81%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
433.043%
|
Peak Bio, Inc.
|
- USD
|
-Infinity%
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
302.646%
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
498.958%
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
413.934%
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
358.784%
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
394.615%
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
239.781%
|
Benitec Biopharma Inc.
|
-5.36 USD
|
171.455%
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
107.797%
|
Adicet Bio, Inc.
|
-3.31 USD
|
215.71%
|
Prime Medicine, Inc.
|
-2.18 USD
|
275.688%
|
Aditxt, Inc.
|
-4326.64 USD
|
100.089%
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
119.16%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
1923.81%
|
Quantum-Si incorporated
|
-0.68 USD
|
663.235%
|
GlycoMimetics, Inc.
|
-0.58 USD
|
760.345%
|
PolyPid Ltd.
|
-16.99 USD
|
122.543%
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
211.988%
|
Invivyd, Inc.
|
-1.81 USD
|
311.602%
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
139.73%
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
365.972%
|
CorMedix Inc.
|
-0.91 USD
|
520.879%
|
Instil Bio, Inc.
|
-24.00 USD
|
115.958%
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
342.405%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
-181.618%
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
108.221%
|
Spero Therapeutics, Inc.
|
0.43 USD
|
-790.698%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
1011.905%
|
AbCellera Biologics Inc.
|
-0.51 USD
|
850.98%
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
451.376%
|
Surrozen, Inc.
|
-21.33 USD
|
117.956%
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
390.152%
|
Verona Pharma plc
|
-0.54 USD
|
809.259%
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
401.575%
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
183.442%
|
Evaxion Biotech A/S
|
-8.11 USD
|
147.226%
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
222.756%
|
Shattuck Labs, Inc.
|
-2.05 USD
|
286.829%
|
AlloVir, Inc.
|
-1.83 USD
|
309.29%
|
BioVie Inc.
|
-7.30 USD
|
152.466%
|
Codexis, Inc.
|
-1.12 USD
|
441.964%
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
385.821%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
479.208%
|
Agenus Inc.
|
-13.75 USD
|
127.855%
|
Virax Biolabs Group Limited
|
-3.36 USD
|
213.988%
|
Lantern Pharma Inc.
|
-1.47 USD
|
360.544%
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
172.128%
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
123.396%
|
Immix Biopharma, Inc.
|
-0.89 USD
|
530.337%
|
Celcuity Inc.
|
-2.69 USD
|
242.379%
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
511.828%
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
454.63%
|
IN8bio, Inc.
|
-1.00 USD
|
483.0%
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
105.204%
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
1420.69%
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
578.75%
|
Liquidia Corporation
|
-1.21 USD
|
416.529%
|
Quantum-Si incorporated
|
-0.68 USD
|
663.235%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
130.277%
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
240.293%
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
479.208%
|
United Therapeutics Corporation
|
21.04 USD
|
81.797%
|
Solid Biosciences Inc.
|
-4.83 USD
|
179.296%
|
Immuneering Corporation
|
-1.88 USD
|
303.723%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
1011.905%
|
uniQure N.V.
|
-6.47 USD
|
159.196%
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
237.77%
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
147.342%
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
379.562%
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
260.251%
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
365.972%
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
1057.5%
|
Cue Biopharma, Inc.
|
-1.11 USD
|
445.045%
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
367.832%
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
771.93%
|
Zura Bio Limited
|
-2.09 USD
|
283.254%
|
Forte Biosciences, Inc.
|
-24.92 USD
|
115.369%
|
Elevation Oncology, Inc.
|
-1.34 USD
|
385.821%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
4336.726%
|
Immunome, Inc.
|
-5.38 USD
|
171.19%
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
1260.606%
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
184.922%
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
162.89%
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
125.033%
|
Altimmune, Inc.
|
-1.66 USD
|
330.723%
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
375.54%
|
Rallybio Corporation
|
-1.84 USD
|
308.152%
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
190.33%
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
145.325%
|
Moolec Science SA
|
-1.50 USD
|
355.333%
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
1296.875%
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
116160.606%
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
143.179%
|
NeurAxis, Inc.
|
-4.03 USD
|
195.037%
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
525.556%
|
Lumos Pharma, Inc.
|
-4.18 USD
|
191.627%
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
184.922%
|
180 Life Sciences Corp.
|
-52.60 USD
|
107.281%
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
171.19%
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
-463.235%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
1082.051%
|
Nutriband Inc.
|
-0.69 USD
|
655.072%
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
124.473%
|
argenx SE
|
-5.16 USD
|
174.225%
|
Neurogene Inc.
|
-2.83 USD
|
235.336%
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
195.75%
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
218.576%
|
CervoMed Inc.
|
-0.82 USD
|
567.073%
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
260.924%
|
Sesen Bio, Inc.
|
-1.99 USD
|
292.462%
|
AnaptysBio, Inc.
|
-6.08 USD
|
162.993%
|
Design Therapeutics, Inc.
|
-1.19 USD
|
421.849%
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
196.231%
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
149.547%
|
Achilles Therapeutics plc
|
-1.74 USD
|
320.115%
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
561.446%
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
295.408%
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
293.434%
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
387.97%
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
624.658%
|
Palisade Bio, Inc.
|
-27.01 USD
|
114.18%
|
Beam Therapeutics Inc.
|
-1.72 USD
|
322.674%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
290.547%
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
115.794%
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
302.646%
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
498.958%
|
Athira Pharma, Inc.
|
-3.10 USD
|
223.548%
|
Vaccinex, Inc.
|
-43.68 USD
|
108.768%
|
HCW Biologics Inc.
|
-0.70 USD
|
647.143%
|
XOMA Corporation
|
-4.04 USD
|
194.802%
|
Nektar Therapeutics
|
-1.45 USD
|
364.138%
|
Arvinas, Inc.
|
-6.62 USD
|
157.855%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
957600.0%
|
Merus N.V.
|
-3.00 USD
|
227.667%
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
312.778%
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
555.952%
|
Rezolute, Inc.
|
-1.33 USD
|
387.97%
|
Clene Inc.
|
-9.43 USD
|
140.615%
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
308.152%
|
BeyondSpring Inc.
|
-0.54 USD
|
809.259%
|
Synlogic, Inc.
|
-8.81 USD
|
143.473%
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
37284.466%
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
108.172%
|
Peak Bio, Inc.
|
- USD
|
-Infinity%
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
464.762%
|
Krystal Biotech, Inc.
|
0.40 USD
|
-857.5%
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
406.4%
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
174.369%
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
597.403%
|
MannKind Corporation
|
-0.04 USD
|
8668.233%
|
Ikena Oncology, Inc.
|
-1.63 USD
|
334.969%
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
142.603%
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
371.631%
|
Gossamer Bio, Inc.
|
-1.18 USD
|
424.576%
|
CohBar, Inc.
|
-4.13 USD
|
192.736%
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
545.349%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
196.231%
|
Legend Biotech Corporation
|
-2.94 USD
|
230.272%
|
Mural Oncology plc
|
-12.43 USD
|
130.813%
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
148.666%
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
134.818%
|
Disc Medicine, Inc.
|
-3.43 USD
|
211.662%
|
Champions Oncology, Inc.
|
-0.54 USD
|
809.259%
|
REGENXBIO Inc.
|
-6.02 USD
|
163.621%
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
181.663%
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
738.333%
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
223.151%
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
343.949%
|
Vaxart, Inc.
|
-0.57 USD
|
771.93%
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
312.778%
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
698.438%
|
Cellectis S.A.
|
-1.77 USD
|
316.384%
|
Longeveron Inc.
|
-10.22 USD
|
137.476%
|
Repare Therapeutics Inc.
|
-2.23 USD
|
271.749%
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
166.034%
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
379.562%
|
Revolution Medicines, Inc.
|
-3.86 USD
|
199.223%
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
5310.884%
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
591.026%
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
276.498%
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
239.781%
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
1296.875%
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
72.74%
|
Denali Therapeutics Inc.
|
-1.06 USD
|
461.321%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
822.642%
|
Veru Inc.
|
-1.10 USD
|
448.182%
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
783.929%
|
Cingulate Inc.
|
-311.99 USD
|
101.228%
|
Passage Bio, Inc.
|
-1.86 USD
|
305.914%
|
Context Therapeutics Inc.
|
-1.50 USD
|
355.333%
|
Exicure, Inc.
|
-2.11 USD
|
281.517%
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
261.603%
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
494.845%
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
199.223%
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
123.045%
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
219.688%
|
Nuvalent, Inc.
|
-2.17 USD
|
276.498%
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
257.613%
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
247.876%
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
399.219%
|
OmniAb, Inc.
|
-0.51 USD
|
850.98%
|
Anew Medical, Inc.
|
0.14 USD
|
-2635.714%
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
738.333%
|
Lipocine Inc.
|
-3.14 USD
|
221.975%
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
253.815%
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
850.98%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
150.131%
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
511.828%
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
284.135%
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
142.32%
|
Ocugen, Inc.
|
-0.26 USD
|
1573.077%
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
256.967%
|
Q32 Bio Inc.
|
-35.16 USD
|
110.893%
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
1057.5%
|
Alumis Inc. Common Stock
|
-2.99 USD
|
228.094%
|
Equillium, Inc.
|
-0.38 USD
|
1107.895%
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
3830100.0%
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
584.81%
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
101.524%
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
387.97%
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
114.574%
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
317.614%
|
Dominari Holdings Inc.
|
-4.38 USD
|
187.443%
|
Edesa Biotech, Inc.
|
-2.93 USD
|
230.717%
|
vTv Therapeutics Inc.
|
-9.71 USD
|
139.444%
|
Bio-Techne Corporation
|
1.07 USD
|
-257.944%
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
160.506%
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
-76.498%
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
289.604%
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
392.366%
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
221.587%
|
Nkarta, Inc.
|
-2.40 USD
|
259.583%
|
BioCardia, Inc.
|
-8.19 USD
|
146.764%
|
Iterum Therapeutics plc
|
-2.96 USD
|
229.392%
|